Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer/testis antigens: structural and immunobiological properties.

Alexei F Kirkin1, Karine N Dzhandzhugazyan, Jesper Zeuthen

  • 1Department of Tumor Cell Biology, Institute of Cancer Biology, Danish.

Cancer Investigation
|March 21, 2002
PubMed
Summary

Cancer/testis (CT) antigens, like MAGE proteins, are promising targets for cancer immunotherapy due to their tumor-specific expression. Combining CT antigen immunotherapy with chemotherapy may enhance tumor eradication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial.

Journal for immunotherapy of cancer·2025
Same author

Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.

Journal of experimental & clinical cancer research : CR·2025
Same author

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.

Molecular cancer·2024
Same author

A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma.

Neuro-oncology advances·2021
Same author

Adoptive T cell cancer therapy.

Nature materials·2018
Same author

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.

Nature communications·2018

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor-associated antigens recognized by cytotoxic T lymphocytes are crucial for anti-cancer immunotherapy.
  • Cancer/testis (CT) antigens exhibit broad tumor-specific expression, making them ideal targets.
  • The MAGE protein superfamily, a prominent group of CT antigens, includes five families with distinct structural and expression patterns.

Purpose of the Study:

  • To characterize tumor-associated antigens, focusing on cancer/testis (CT) antigens and the MAGE superfamily.
  • To explore the structural organization and potential biological functions of MAGE proteins.
  • To investigate the implications of CT antigen properties for novel anti-cancer immunotherapy strategies.

Main Methods:

  • Structural comparison of MAGE superfamily members to identify conserved and unique domains.

Related Experiment Videos

  • Analysis of CT antigen expression patterns in tumors and normal tissues.
  • Review of existing literature on MAGE proteins, CT antigens, and immunotherapy.

    • Main Results:

    • The MAGE superfamily comprises five families (MAGE-A, -B, -C, -D, necdin) with a conserved central domain and variable flanking domains.
    • MAGE-D proteins possess a unique fourth domain, with MAGE-D3 coinciding with the adhesion molecule trophinin.
    • CT antigens, including MAGE proteins, can be upregulated by DNA demethylating agents.

    Conclusions:

    • Structural classification of MAGE superfamily members aids in understanding their biological functions.
    • The ability of CT antigens to be re-expressed by demethylating agents suggests a synergistic approach.
    • Combining CT antigen-targeted immunotherapy with chemotherapy that upregulates CT antigens may lead to more effective tumor eradication.